Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Explore stem cell collection with or without bortezomib with in-vivo purging in multiple myeloma.
Epistemonikos ID: cf66d9d264411d8d6541226426b7956dfb4d6bd9
First added on: May 12, 2024